Context Therapeutics CNTX
NASDAQ CNTX
$0.24 +0.01 (+2.27%)
At close: Oct 20, 2026 · 4:00 PM EDT

Context Therapeutics (CNTX) Operating Leases (2022 - 2026)

Updated

Context Therapeutics (CNTX) reported Operating Leases of $77,524 for Q2 2026, up 48.1% from $52,334 a year earlier but down 36.6% from the prior quarter.

Analysis

Context Therapeutics (CNTX) Operating Leases (2022 - 2026) Analysis & Trends

At the end of FY2024, Context Therapeutics posted Operating Leases of $112,064.

  • Five-year quarterly Operating Leases spans a low of $7,967 in Q2 2022 and a high of $140,200 in Q3 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn
10 Context Therapeutics 23.00 Mn -217.47 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 77,524.00
Mar 31, 2026 122,369.00
Sep 30, 2025 21,220.00
Jun 30, 2025 52,334.00
Mar 31, 2025 82,608.00
Dec 31, 2024 112,064.00
Sep 30, 2024 140,200.00
Jun 30, 2022 7,967.00
Mar 31, 2022 31,669.00
API Access

Context Therapeutics Operating Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-leases&ticker=CNTX&period=max&api_key=YOUR_API_KEY